The impact of some non-drug treatments on the state of endotoxin-binding systems and level of systemic inflammation in patients with bronchial asthma in post-COVID period

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

INTRODUCTION: Bronchial asthma (BA) is one most common disease in the world, with complete control not exceeding 50%. A relevant research trend is the search for new methods of achieving control over BA, taking into account personalized approach.

AIM: Based on laboratory markers of endotoxin-binding systems and systemic inflammation, to evaluate the effectiveness of magnetic therapy (MT) and ‘dry’ carbon dioxide baths (DCDB) in combination with grape polyphenols (GP) in spa treatment of BA patients with past coronavirus infection.

METHODS: Patients (n=75) undergoing spa treatment in the Pulmonology Department of the Sechenov Academic Research Institute of Physical Treatment Methods, Medical Climatology and Rehabilitation, were divided into 3 groups: group 1 (n=25) — patients who additionally received MT and GP concentrate during treatment, group 2 (n=25) — DCDB and GP concentrate, group 3 (n=25) — only standard spa treatment. Before admission and after treatment, blood plasma was collected for analysis for the following markers: C reactive protein (CRP), bactericidal permeability increasing protein (BPI), lipopolysaccharide-binding protein (LBP), lipopolysaccharide, soluble form of CD14 protein (sCD14), zonulin.

RESULTS: The CRP level decreased only in group 1 — from 2.93 to 1.93 mg/l (p=0.011). The BPI level increased in all groups: in group 1 — from 65.50 to 70.70 pg/ml (p=0.012), in group 2 — from 57.60 to 95.00 pg/ml (p <0.001), in group 3 — from 64.90 to 88.30 pg/ml (p=0.008). The level of sCD14, which was initially absent in the blood of patients, after spa treatment increased to 1.54 ng/l in group 1 (p=0.003), to 7.20 ng/l (p <0.001) in group 2 and to 6.40 ng/l (p <0.001) in group 3. The level of zonulin increased several-fold in all groups: in group 1 — from 4.94 to 275.60 ng/ml (p <0.001), in group 2 — from 0.20 to 40.70 ng/ml (p <0.001), in group 3 — from 0.90 to 127.50 ng/ml (p=0.002).

CONCLUSION: Use of magnetic therapy and ‘dry’ carbon dioxide baths in combination with grape polyphenol concentrate enhances the effectiveness of classic spa treatment in patients with BA with past coronavirus infection: it activates endotoxin-binding systems and inhibits increased intestinal permeability. Magnetic therapy also reduces systemic inflammation.

About the authors

Evgeny D. Kumelsky

V.I. Vernadsky Crimean Federal University

Author for correspondence.
Email: ekum.rk@yandex.ru
ORCID iD: 0000-0001-5090-4516
SPIN-code: 5712-1275
Russian Federation, Simferopol

Vladimir A. Beloglazov

V.I. Vernadsky Crimean Federal University

Email: biloglazov@mail.ru
ORCID iD: 0000-0001-9640-754X
SPIN-code: 7455-2188

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Simferopol

Igor A. Yatskov

V.I. Vernadsky Crimean Federal University

Email: egermd@yandex.ru
ORCID iD: 0000-0002-5486-7262
SPIN-code: 2395-5710

MD, Cand. Sci. (Medicine)

Russian Federation, Simferopol

Galina N. Andreeva

V.I. Vernadsky Crimean Federal University

Email: galinaandreeva2901@internet.ru
ORCID iD: 0000-0002-1876-0011
SPIN-code: 9443-7134
Russian Federation, Simferopol

Arsen S. Ebubekirov

V.I. Vernadsky Crimean Federal University

Email: arsenebubekirov0@gmail.com
ORCID iD: 0009-0006-5966-0996
Russian Federation, Simferopol

Saliha E. Khodzhametova

V.I. Vernadsky Crimean Federal University

Email: salisunny9@gmail.com
ORCID iD: 0009-0004-4828-9293
Russian Federation, Simferopol

References

  1. Cherepanova SA, Meshcheryakov VV. Influence of Psychological Factors on Treatment Adherence, Control Level and Quality of Life of Children with Bronchial Asthma. Vestnik SurGU. Meditsina. 2022;(2):59–64. doi: 10.34822/2304-9448-2022-2-59-64 EDN: OJKYPG
  2. Avdeev SN, Nenasheva NM, Zhudenko KV, et al. Prevalence, morbidity, phenotypes and other characteristics of severe bronchial asthma in Russian Federation. Pulmonologiya. 2018;28(3):341–358. doi: 10.18093/0869-0189-2018-28-3-341-358 EDN: XWCRRZ
  3. Beloglazov VA, Yatskov IA, Kumelsky ED, Polovinkina VV. Metabolic endotoxemia: possible causes and consequences. Obesity and Metabolism. 2021;18(3):320–326. doi: 10.14341/omet12750 EDN: OHPPVU
  4. Grakhova MA, Troshina IA, Golubeva TI, et al. The role of endotoxin in the aspect of the «gut-lung» axis in patients with bronchial asthma in combination with obesity (literature review). Medical Science and Education of Ural. 2023;24(1):158–162. EDN: EDEJQL
  5. Beloglazov VA, Popenko YuO, Gordienko AI, Tumanova EL. Endotoxin and asthma: friends or foes? Pathogenesis. 2020;18(1):17–28. doi: 10.25557/2310-0435.2020.01.17-28 EDN: JWGMIZ
  6. Beloglazov VA, Yatskov IA, Useinova RKh. Low-grade inflammation in the post-COVID period as a strategic goal of treatment and rehabilitation. Acta Biomedica Scientifica. 2024;9(2):24–34. doi: 10.29413/ABS.2024-9.2.3 EDN: EJWDNA
  7. León-Pedroza JI, González-Tapia LA, del Olmo-Gil E, et al. [Low-grade systemic inflammation and the development of metabolic diseases: from the molecular evidence to the clinical practice]. Cir Cir. 2015;83(6):543–551. (In Spanish). doi: 10.1016/j.circir.2015.05.041
  8. Abdulan IM, Feller V, Oancea A, et al. Evolution of Cardiovascular Risk Factors in Post-COVID Patients. J Clin Med. 2023;12(20):6538. doi: 10.3390/jcm12206538 EDN: IZMMEO
  9. Tanizaki Y. Spa Therapy for Bronchial Asthma. Journal of Japanese Association of Physical Medicine Balneology and Climatology. 1991;54(4): 197–204. doi: 10.11390/onki1962.54.197
  10. Lobanov AA, Grishechkina IA, Andronov SV, et al. Health and spa treatment in bronchial asthma: the efficiency of the method and the techniques. Journal of New Medical Technologies. 2021;28(4):83–91. EDN: UWGYON
  11. Yusupalieva MM, Golubev ON, Chudinova DS. Novyye podkhody sanatorno-kurortnogo lecheniya bol'nykh bronkhial'noy astmoy na etape reabilitatsii. Herald of Physiotherapy and Health Resort Therapy. 2021;27(2):90. (In Russ.) EDN: LRTIIG
  12. Ross CL, Harrison BS. The use of magnetic field for the reduction of inflammation: a review of the history and therapeutic results. Altern Ther Health Med. 2013;19(2):47–54. EDN: RKLEBB
  13. Shang W, Chen G, Li Y, et al. Static Magnetic Field Accelerates Diabetic Wound Healing by Facilitating Resolution of Inflammation. J Diabetes Res. 2019;2019:5641271. doi: 10.1155/2019/5641271
  14. Bodrova RA, Kuchumova TV, Zakamyrdina AD, et al. Efficacy of Low-Frequency Magnetic Therapy in Patients with COVID-19 Pneumonia. Problems of Balneology, Physiotherapy and Exercise Therapy. 2020; 97(6):11–16. doi: 10.17116/kurort20209706111 EDN: HTNQTA
  15. Silantyeva ES. The Application of High Intensity and Low Intensity Magnetotherapy in Rehabilitation of Patients with COVID-19: A Randomized Controlled Pilot Study. Physical and Rehabilitation Medicine, Medical Rehabilitation. 2020;2(4):322–328. doi: 10.36425/rehab50236 EDN: VPYVWV
  16. Ezhov VV, Tsarev AYu, Platunova TE. Application of dry carbon baths in clinical practice (scientific review). Herald of Physiotherapy and Health Resort Therapy. 2017;23(2):63–76. EDN: HXXWNS
  17. Kabirova EF, Borisova AI, Urmantseva FA, et al. Use of dry carbonic baths in complex treatment of patients with occupational asthma. Occupational Health and Human Ecology. 2019;(1):72–77. doi: 10.24411/2411-3794-2019-10012 EDN: GMCDFB
  18. Chernousova IV, Zaitsev GP, Zhilyakova TA, et al. Grape processing products with a regulated amount of polyphenols: properties, biological efficiency. Viticulture and Winemaking. 2023;52:94–96. EDN: QEVFGF
  19. Petrenko VI, Kubyshkin AV, Fomochkina II, et al. Research of anti-inflammatory and anti-diabetic action of grape polyphenols on the experimental model of metabolic syndrome. Viticulture and Winemaking. 2020;49:243–245. EDN: ZGGGSU
  20. Beloglazov VA, Yatskov IA, Moik AA, Moik AV. Prospects for the use of polyphenols in patients with bronchial asthma and obesity. Obesity and Metabolism. 2024;21(4):357–364. doi: 10.14341/omet13092 EDN: IZYOZR
  21. Trudnaya v lechenii astma. Intuitivnyye tekhnologii i real'nyy mir patsiyenta. Effective Pharmacotherapy. 2019;15(37):74–80. (In Russ.) EDN: YABDYT
  22. Grakhova MA, Troshina IA, Golubeva TI, Yuzhakova NU. Exploring the predictive potential of endotoxin and zonulin in conjunction with obesity for assessing bronchial asthma severity. Medical Science and Education of Ural. 2023;24(4):27–31. EDN: TLPZKI
  23. Xingyuan Cn, Chen Q. Serum BPI as a novel biomarker in asthma. Allergy Asthma Clin Immunol. 2020;16:50. doi: 10.1186/s13223-020-00450-0 EDN: CIHVTF
  24. Levitan BN, Kasyanova TR, Voloshina OA. Clinical and diagnostic significance of the lipopolysaccharide-binding protein and the soluble cluster of differentiation 14 in chronic hepatitis and liver cirrhosis. Experimental and Clinical Gastroenterology. 2018;(9):32–37. doi: 10.31146/1682-8658-ecg-157-9-32-37 EDN: ZRCDSL
  25. Avidzba AM, Kubyshkin AV, Guguchkina TI, et al. The antioxidant activity of the products of processing of red grape of Cabernet Sauvignon, Merlot, Saperavi. Nutrition Issues. 2016;85(1):99–109. EDN: KUBODB
  26. Dai X, Ding Y, Zhang Z, et al. Quercetin and quercitrin protect against cytokine-induced injuries in RINm5F β-cells via the mitochondrial pathway and NF-κB signaling. Int J Mol Med. 2013;31(1):265–271. doi: 10.3892/ijmm.2012.1177
  27. Wu H, Li C, Masood M, et al. Static Magnetic Fields Regulate T-Type Calcium Ion Channels and Mediate Mesenchymal Stem Cells Proliferation. Cells. 2022;11(15):2460. doi: 10.3390/cells11152460 EDN: WITTYY
  28. Marcos V, Latzin P, Hector A, et al. Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases. Respir Res. 2010;11(1):32. doi: 10.1186/1465-9921-11-32 EDN: ZYXMDE
  29. Khavkin AI, Bogdanova NM, Novikova VP. Biological role of zonulin: a biomarker of increased intestinal permeability syndrome. Russian Bulletin of Perinatology and Pediatrics. 2021;66(1):31–38. doi: 10.21508/1027-4065-2021-66-1-31-38 EDN: YWHGPS
  30. Veres-Székely A, Szász C, Pap D, et al. Zonulin as a Potential Therapeutic Target in Microbiota-Gut-Brain Axis Disorders: Encouraging Results and Emerging Questions. Int J Mol Sci. 2023;24(8):7548. doi: 10.3390/ijms24087548 EDN: SFYTLD
  31. Palomino-Kobayashi LA, Ymaña B, Ruiz J, et al. Zonulin, a marker of gut permeability, is associated with mortality in a cohort of hospitalised peruvian COVID-19 patients. Front Cell Infect Microbiol. 2022;12:1000291. doi: 10.3389/fcimb.2022.1000291 EDN: JJOOAV Erratum in: Front Cell Infect Microbiol. 2022;12:1062174. doi: 10.3389/fcimb.2022.1062174 EDN: UZWEKS
  32. La Torre D, van Oudenhove L, Vanuytsel T, Verbeke K. Psychosocial stress-induced intestinal permeability in healthy humans: What is the evidence? Neurobiol Stress. 2023;27:100579. doi: 10.1016/j.ynstr.2023.100579 EDN: OMFVUC

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).